However, HLA-related gene expression promotes immune responses to clear tumors, while immune checkpoint genes (PDL1, CTLA4, TIM-3, and CD276) suppress immune responses and facilitate tumor proliferation and metastasis. The gene discussed is HAVCR2; the disease is neoplasm.